Forecast: Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases in Canada

The forecasted number of RR-/MDR-TB cases in Canada shows a gradual increase from 2024 to 2028. Starting at 24 cases in 2024, the number increases to 26 cases by 2028, highlighting a slight but steady upward trend. The year-on-year variations remain minor, reflecting about a 4% average annual increase over this period. In 2023, the actual number of RR-/MDR-TB cases stood at 24.

Future trends to watch for include:

  • Advancements in diagnostic and treatment protocols which could impact case numbers.
  • Alterations in public health policies and their effect on controlling RR-/MDR-TB spread.
  • Evolving patterns related to global travel and their influence on TB transmission rates in Canada.

Top Countries about Tuberculosis